Treatment with OE‐ALKBH5 Exo significantly restored ALKBH5 expression and suppressed TRAF6 expression, supporting the potential involvement for the ALKBH5‐TRAF6 regulatory axis in DKD. This evidence concerns the gene ALKBH5 and diabetic kidney disease.